These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 16189121)

  • 1. Effect of amphotericin B on capsule and cell size in Cryptococcus neoformans during murine infection.
    Zaragoza O; Mihu C; Casadevall A; Nosanchuk JD
    Antimicrob Agents Chemother; 2005 Oct; 49(10):4358-61. PubMed ID: 16189121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of amphotericin B in combination with flucytosine against flucytosine-susceptible or flucytosine-resistant isolates of Cryptococcus neoformans during disseminated murine cryptococcosis.
    Schwarz P; Dromer F; Lortholary O; Dannaoui E
    Antimicrob Agents Chemother; 2006 Jan; 50(1):113-20. PubMed ID: 16377675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of NS-718, a novel lipid nanosphere-encapsulated amphotericin B, against Cryptococcus neoformans.
    Hossain MA; Maesaki S; Kakeya H; Noda T; Yanagihara K; Sasaki E; Hirakata Y; Tomono K; Tashiro T; Kohno S
    Antimicrob Agents Chemother; 1998 Jul; 42(7):1722-5. PubMed ID: 9661011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brilacidin, a novel antifungal agent against
    Diehl C; Pinzan CF; de Castro PA; Delbaje E; García Carnero LC; Sánchez-León E; Bhalla K; Kronstad JW; Kim D-g; Doering TL; Alkhazraji S; Mishra NN; Ibrahim AS; Yoshimura M; Vega Isuhuaylas LA; Pham LTK; Yashiroda Y; Boone C; Dos Reis TF; Goldman GH
    mBio; 2024 Jul; 15(7):e0103124. PubMed ID: 38916308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serotypes of clinical cerebrospinal fluid Cryptococcus neoformans isolates from southern Taiwan and their in vitro susceptibilities to amphotericin B, fluconazole, and voriconazole.
    Chang WN; Huang CR; Lei CB; Lee PY; Chien CC; Chang HW; Chang CS; Lu CH
    Jpn J Infect Dis; 2004 Jun; 57(3):113-5. PubMed ID: 15218221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic effect of pedalitin and amphotericin B against Cryptococcus neoformans by in vitro and in vivo evaluation.
    Sangalli-Leite F; Scorzoni L; Alves de Paula E Silva AC; da Silva JF; de Oliveira HC; de Lacorte Singulani J; Gullo FP; Moraes da Silva R; Regasini LO; Siqueira da Silva DH; da Silva Bolzani V; Fusco-Almeida AM; Soares Mendes-Giannini MJ
    Int J Antimicrob Agents; 2016 Nov; 48(5):504-511. PubMed ID: 27742203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro interaction of antifungal and antibacterial drugs against Cryptococcus neoformans var. grubii before and after capsular induction.
    Rossato L; Loreto ÉS; Venturini TP; Azevedo MI; Weiblen C; Botton SA; Santurio JM; Alves SH
    Med Mycol; 2015 Nov; 53(8):885-9. PubMed ID: 26333356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of Off-Patent Drugs That Show Synergism with Amphotericin B or That Present Antifungal Action against Cryptococcus neoformans and
    Rossi SA; de Oliveira HC; Agreda-Mellon D; Lucio J; Mendes-Giannini MJS; García-Cambero JP; Zaragoza O
    Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 31988099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo and in vitro antifungal activity of the polyene derivative SPA-S-753 against encapsulated form of Cryptococcus neoformans.
    Strippoli V; D'Auria FD; Simonetti N; Basti D; Bruzzese T
    Infection; 1997; 25(1):27-31. PubMed ID: 9039534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New Triazole NT-a9 Has Potent Antifungal Efficacy against Cryptococcus neoformans
    Lu RY; Ni TJ; Wu J; Yan L; Lv QZ; Li LP; Zhang DZ; Jiang YY
    Antimicrob Agents Chemother; 2020 Jan; 64(2):. PubMed ID: 31791946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quercetin and rutin as potential agents antifungal against Cryptococcus spp.
    Oliveira VM; Carraro E; Auler ME; Khalil NM
    Braz J Biol; 2016; 76(4):1029-1034. PubMed ID: 27166572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo studies on synergistic antifungal activity.
    Shadomy S
    Contrib Microbiol Immunol; 1977; 4():147-57. PubMed ID: 342191
    [No Abstract]   [Full Text] [Related]  

  • 13. Synergistic effect of the verapamil and amphotericin B against Cryptococcus neoformans.
    Pereira TC; do Carmo PHF; de Menezes RT; de Oliveira HC; de Oliveira LD; Junqueira JC; Scorzoni L
    Folia Microbiol (Praha); 2023 Dec; 68(6):999-1004. PubMed ID: 37950840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluconazole and amphotericin B susceptibility testing of Cryptococcus neoformans: results of minimal inhibitory concentrations against 265 isolates from HIV-positive patients before and after two or more months of antifungal therapy.
    Arechavala AI; Ochiuzzi ME; Borgnia MD; Santiso GM
    Rev Iberoam Micol; 2009 Sep; 26(3):194-7. PubMed ID: 19635445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antifungal susceptibilities of Cryptococcus neoformans cerebrospinal fluid isolates and clinical outcomes of cryptococcal meningitis in HIV-infected patients with/without fluconazole prophylaxis.
    Manosuthi W; Sungkanuparph S; Thongyen S; Chumpathat N; Eampokalap B; Thawornwan U; Foongladda S
    J Med Assoc Thai; 2006 Jun; 89(6):795-802. PubMed ID: 16850679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antifungal susceptibility of Cryptococcus neoformans to amphotericin B and fluconazole.
    Khyriem AB; Sujatha S; Parija SC
    Indian J Pathol Microbiol; 2006 Apr; 49(2):307-8. PubMed ID: 16933750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amphotericin B resistant isolates of Cryptococcus neoformans without alteration in sterol biosynthesis.
    Joseph-Horne T; Loeffler RS; Hollomon DW; Kelly SL
    J Med Vet Mycol; 1996; 34(3):223-5. PubMed ID: 8803806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The combined effect of 5-fluorocytosine and amphotericin B in the therapy of murine cryptococcosis.
    Block ER; Bennett JE
    Proc Soc Exp Biol Med; 1973 Feb; 142(2):476-80. PubMed ID: 4570039
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of experimental systemic mycoses with BRL 49594A.
    Najvar LK; Luther MF; Graybill JR
    J Antimicrob Chemother; 1995 Dec; 36(6):1005-1011. PubMed ID: 8821599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro antifungal activities of amphotericin B, 5-fluorocytosine, fluconazole and itraconazole against Cryptococcus neoformans isolated from cerebrospinal fluid and blood from patients in Serbia.
    Trpković A; Pekmezović M; Barać A; Crnčević Radović L; Arsić Arsenijević V
    J Mycol Med; 2012 Sep; 22(3):243-8. PubMed ID: 23518082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.